Brazilian Thalassemia Association protocol for iron chelation therapy in patients under regular transfusion

In the absence of an iron chelating agent, patients with beta-thalassemia on regular transfusions present complications of transfusion-related iron overload. Without iron chelation therapy, heart disease is the major cause of death; however, hepatic and endocrine complications also occur. Currently...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Monica Pinheiro de Almeida Verissimo, Sandra Regina Loggetto, Antonio Fabron Junior, Giorgio Roberto Baldanzi, Nelson Hamerschlak, Juliano Lara Fernandes, Aderson da Silva Araujo, Clarisse Lopes de Castro Lobo, Kleber Yotsumoto Fertrin, Vasilios Antonios Berdoukas, Renzo Galanello
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2013-01-01
Colecção:	Revista Brasileira de Hematologia e Hemoterapia
Assuntos:	Blood transfusion Chelation therapy Deferiprone Deferasirox Iron/metabolism beta-Thalassemia Iron overload Iron chelating agents Magnetic resonance imaging Practice guidelines as topic Protocols Brazil
Acesso em linha:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842013000600428&lng=en&tlng=en
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!